Fluorine-containing cytidine guanidine compound as well as preparation method and application thereof
By designing and synthesizing fluorine-containing cytidine guanidine compounds 8-5, the existing antiviral pesticides have been solved, and the effective prevention and treatment of plant viruses and pathogens has been achieved, which has demonstrated a safer and more environmentally friendly Green pesticide applications.
Patent Information
- Application Number
- CN202411269435.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-07-24
- Filing Date
- 2024-09-11
- Publication Date
- 2024-11-26
AI Technical Summary
The existing antiviral pesticides have problems of high contamination and poor efficacy, especially in the prevention and treatment of plant viruses and pathogens.
A fluorine-containing cytidine guanidine compound 8-5 was designed and prepared by a multi-step synthesis method. It is used as an antiviral agent and a bactericide, combined with traditional bactericides to improve the agricultural prevention and control effect.
Compound 8-5 has good solubility and stability, and has a strong inhibitory effect on plant viruses such as PVY and TuMV. It is safer and more environmentally friendly than traditional chemical pesticides, and is in line with the concept of green pesticide development.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of agricultural chemicals, and in particular to a fluorine-containing cytidine guanidine compound and a preparation method and application thereof. Background Art
[0002] Guanidine drugs can form non-covalent interactions with proteins and molecular targets, bind anions such as carboxylates, phosphates, sulfides, charge pairing and cation-π interactions through hydrogen bonds, and the guanidine functional group shows good application prospects in synthesis and medicinal chemistry. In recent years, guanidine derivative pesticides and synthetic new guanidine compounds have emerged in an endless stream, such as agricultural antibiotic streptomycin, fungicides chlorhexidine and metformin, antiviral agent morpholinoguanidine hydrochloride, etc. In medicinal chemistry, the introduction of fluorine atoms can regulate the lipophilicity, pKa, conformation and bioavailability of drug molecules.
[0003] The present invention utilizes the principle of pesticide molecule design, introduces guanidine group into the lead structure of cytidine nucleoside, designs and synthesizes a fluorine-containing cytidine guanidine compound, and conducts systematic biological activity screening to provide new high-efficiency candidate compounds for the creation of new pesticides.
[0004] Therefore, the design of existing antiviral pesticides needs to be improved and enhanced. Summary of the invention
[0005] In view of the above-mentioned deficiencies in the prior art, the purpose of the present invention is to provide a fluorine-containing cytidine guanidine compound and a preparation method and use thereof, aiming to solve the problems of high pollution and poor efficacy of pesticides in the prior art.
[0006] In order to achieve the above object, the present invention adopts the following technical solutions: In the first aspect, the structural formula of the fluorine-containing cytidine compound 8-5 of the present invention is: The synthesis method of the fluorine-containing cytidine guanidine compound 8-5 of the present invention is as follows: The specific steps are as follows: A. Preparation of compound 8-1: 4-12 g of the compound (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyric acid and 4-12 g of cytidine nucleoside were added to a 50 ml round-bottom flask, vacuumed, and then 5-10 ml of dry N,N-dimethylformamide (DMF) was added as a solvent, and then 2-6 g of 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU) and 2-8 g of N,N-diisopropylethylamine (DIEA) were added as condensation agents, and the mixture was stirred at 25-35°C for 4-16 hours. The reaction was monitored by silica gel thin layer chromatography, and ethyl acetate: petroleum ether = 1-4:2-5 was used as the chromatography liquid. The reaction mixture was purified by pentafluorophenyl column with ACN / H2O (v / v=2-8 / 1-4) to obtain compound 8-1, i.e. ((R)-4-((1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate. The amount of compound 8-1 prepared and the volume of the reaction container were enlarged or reduced in the corresponding proportion.
[0007] B. Preparation of compound 8-2: 4-12 g of ((R)-4-((1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate and 2-6 g of acetic anhydride were added to a 50 ml round-bottom flask, vacuumed, and then 15-30 ml of acetonitrile (ACN) was added as a solvent, and 1-8 g of N,N-diisopropylethylamine (DIEA) was added as a condensation agent, and the mixture was stirred at room temperature for 3-6 hours. The reaction was monitored by silica gel thin layer chromatography, and ethyl acetate: petroleum ether = 1-4:2-5 was used as the chromatography liquid. The reaction mixture was purified by a pentafluorophenyl column with ACN / H2O (v / v=2-8 / 1-4) to obtain compound 8-2, i.e. ((2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-((tert-butyloxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-2 prepared and the volume of the reaction container were enlarged or reduced in the corresponding proportion.
[0008] C. Preparation of compound 8-3: 4-12 g of ((2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-((tert-butyloxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate was added to a 25 ml round-bottom flask, and vacuum was applied. Then, 1-8 ml of trifluoroacetic acid (TFA) and 5-15 ml of dichloromethane (DCM) were added, and the mixture was stirred at room temperature for 3-5 hours. The progress of the reaction was monitored by silica gel thin layer chromatography. Ethyl acetate: petroleum ether = 1-4: 2-5 was used as the chromatographic liquid. The reaction mixture was purified by a pentafluorophenyl column using ACN / H2O (v / v = 1-4 / 1-4) to obtain compound 8-3, i.e. (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-3 prepared and the volume of the reaction container were enlarged or reduced in the corresponding proportion.
[0009] D. Preparation of compound 8-4: 4-8 g of (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate and 2-4 g of 1,1-di-tert-butyloxycarbonyl-2-(trifluoromethylsulfonyl)guanidine are added to a 50 ml round-bottom flask, evacuated, and then 5-10 ml of dry N,N-dimethylformamide (DMF) is added as a solvent, and then 1-5 g of N,N-diisopropylethylamine (DIEA) is added as a condensation agent, and the mixture is stirred at room temperature for 16-24 hours. The reaction is monitored by silica gel thin layer chromatography, using ethyl acetate: petroleum ether = 1-4:2-5 as a chromatographic liquid. The reaction mixture was purified by a pentafluorophenyl column with ACN / H2O (v / v=4-8 / 6-12) to obtain compound 8-4, i.e., (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-(((R)-3-(2,3-bis(tert-butyloxycarbonyl)guanidino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-4 prepared and the volume of the reaction container were enlarged or reduced in the corresponding proportion.
[0010] E. Preparation of compound 8-5: 2-8 g of (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-(((R)-3-(2,3-bis(tert-butyloxycarbonyl)guanidino)-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate and 6-12 ml of hydrochloric acid were added to a 50 ml round-bottom flask, and the mixture was stirred at room temperature for 3-6 hours after vacuumization. The reaction was monitored by silica gel thin layer chromatography using ethyl acetate:petroleum ether = 1 ~4:2~5 as the chromatographic liquid. The reaction mixture was purified by a pentafluorophenyl column with ACN / H2O (v / v=3~6 / 7~14) to obtain compound 8-5, i.e. (R)-N-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-3-guanidino-4-(2,4,5-trifluorophenyl)butanamide. The amount of compound 8-5 prepared and the volume of the reaction container were enlarged or reduced in the corresponding proportion.
[0011] Another object of the present invention is to provide the use of fluorine-containing cytidine guanidine compound 8-5 as an antiviral agent and fungicide in agriculture.
[0012] The viruses are potato virus Y (PVY), turnip mosaic virus (TuMV) and tobacco mosaic virus (TMV), and are used for the prevention and treatment of diseases thereof.
[0013] The pathogen is tobacco target spot pathogen ( Rhizoctonia solani )、Rhizoctonia solani( Rhizoctonia nightshade )、Tobacco root rot pathogen ( Fusarium oxysporum )、Curvularia zea maydis ( Curvularlunate )、Pythium aphanidermatum( Pythium aphanidermatum ), used for the prevention and treatment of its diseases.
[0014] Another object of the present invention is to provide a sterilization application of the fluorine-containing cytidine guanidine compound 8-5 in combination with a commercial antiviral agent.
[0015] The fluorine-containing cytidine guanidine compound 8-5 described in claim 1 is combined with any one or two of the commercial fungicides to form a fungicide composition for preventing and controlling agricultural, forestry and horticultural plant diseases, and the commercial fungicides are selected from: azoxystrobin, jinggangmycin, metalaxyl, kasugamycin, methyl thiophanate, mebendazole, carbendazim, mancozeb, thiram, benomyl, bensulfuron, thiabendazole, sclerotin, procymidone, propamocarb, polyoxin, oxepiconazole, propiconazole, prothioconazole, picoxystrobin, benoxystrobin, thiopyrad, imazalil, quinclorac, thiopyrad, flutolanil, fluoxastrobin, kresoxim-butyl, benoxystrobin, oxazolidinone, pyraclostrobin, picoxystrobin, pyraclostrobin, trifloxystrobin, enoxadone, and enoxadone. The mass percentage of the fluorine-containing cytidine guanidine compound 8-5 described in claim 1 in the fungicide composition is 1%-90%, and the mass percentage of the fluorine-containing cytidine guanidine compound 8-5 described in claim 1 to the aforementioned commercial fungicide is 1%:99% to 99%:1%; the dosage form processed by the fungicide composition is selected from: seed treatment emulsion, aqueous emulsion, microemulsion, suspoemulsion, soluble concentrate, microgranule oil suspension, oil dispersible powder; the plant diseases controlled by the fungicide composition are selected from: rice sheath blight, corn leaf spot, corn leaf spot, rice blast, tobacco target spot, tobacco brown spot, wheat fusarium, pepper anthracnose, tobacco root rot, corn curvature leaf spot, fruit pythium, eggplant brown streak, tomato root rot, strawberry powdery mildew, potato late blight, tobacco black shank, wheat rust, grape downy mildew, cucumber downy mildew, cucumber anthracnose, tomato gray mold; the plants controlled by the fungicide composition are selected from: Rice, wheat, barley, oats, corn, sorghum, cucumber, pepper, potato, sweet potato, cassava, rapeseed, cabbage, beet, tomato, tobacco, soybean, snow pea, broad bean, pea, mung bean, adzuki bean, cotton, sericulture, peanut, rapeseed, sesame, sunflower, sugarcane.
[0016] The technical solution adopted in the present invention has the following beneficial effects: it has good solubility and stability, has a strong inhibitory effect on plant viruses such as PVY, TuMV, TMV, and has good binding ability with the CP and HC-Pro proteins of PVY and TuMV viruses. Compared with traditional chemical pesticides, it is safer and more environmentally friendly, and in line with the concept of green pesticide development. DETAILED DESCRIPTION
[0017] Example 1 Preparation of compound 8-5 4 g of the compound (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyric acid and 4 g of cytidine were added to a 50 ml round-bottom flask, vacuumed, and then 8 ml of dry N,N-dimethylformamide (DMF) was added as a solvent, and then 2 g of 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU) and 2 g of N,N-diisopropylethylamine (DIEA) were added as condensation agents, and the mixture was stirred at 28°C for 6 hours. The reaction was monitored by silica gel thin layer chromatography, using ethyl acetate: petroleum ether = 1:2 as the chromatographic liquid. The reaction mixture was purified by pentafluorophenyl column with ACN / H2O (v / v=2 / 4) to obtain compound 8-1, i.e. ((R)-4-((1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate. The amount of compound 8-1 prepared and the volume of the reaction container were scaled up or down in the corresponding proportion.
[0018] 4 g of ((R)-4-((1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate and 2 g of acetic anhydride were added to a 50 ml round-bottom flask, vacuumed, and then 15 ml of acetonitrile (ACN) was added as a solvent, and 2 g of N,N-diisopropylethylamine (DIEA) was added as a condensation agent, and the mixture was stirred at room temperature for 4 hours. The reaction was monitored by silica gel thin layer chromatography, using ethyl acetate: petroleum ether = 1:2 as the chromatographic solvent. The reaction mixture was purified by pentafluorophenyl column with ACN / H2O (v / v=2 / 1) to obtain compound 8-2, i.e. ((2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-((tert-butyloxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-2 prepared and the volume of the reaction container were scaled up or down in the corresponding proportions.
[0019] 4 g of ((2R,3R,4R,5R)-2-(acetoxymethyl)-5-(4-((R)-3-((tert-butyloxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate was added to a 25 ml round-bottom flask, and vacuum was applied. Then, 2 ml of trifluoroacetic acid (TFA) and 5 ml of dichloromethane (DCM) were added, and the mixture was stirred at room temperature for 3 hours. The progress of the reaction was monitored by silica gel thin layer chromatography. Ethyl acetate: petroleum ether = 2:3 was used as the chromatography liquid. The reaction mixture was purified by a pentafluorophenyl column using ACN / H2O (v / v = 1 / 1) to obtain compound 8-3, i.e. (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-3 prepared and the volume of the reaction container were enlarged or reduced in the corresponding proportion.
[0020] 4 g of (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate and 2 g of 1,1-di-tert-butyloxycarbonyl-2-(trifluoromethylsulfonyl)guanidine were added to a 50 ml round-bottom flask, vacuumed, and then 8 ml of dry N,N-dimethylformamide (DMF) was added as a solvent, and 1 g of N,N-diisopropylethylamine (DIEA) was added as a condensation agent, and the mixture was stirred at room temperature for 16 hours. The progress of the reaction was monitored by silica gel thin layer chromatography, using ethyl acetate: petroleum ether = 2:4 as the chromatographic solvent. The reaction mixture was purified by a pentafluorophenyl column with ACN / H2O (v / v=4 / 6) to obtain compound 8-4, i.e., (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-(((R)-3-(2,3-bis(tert-butyloxycarbonyl)guanidino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-4 prepared and the volume of the reaction container were scaled up or down in the corresponding proportions.
[0021] 2 g of (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-(((R)-3-(2,3-bis(tert-butyloxycarbonyl)guanidino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate and 6 ml of hydrochloric acid were added to a 50 ml round-bottom flask, and vacuum was applied. The mixture was stirred at room temperature for 3 hours. The progress of the reaction was monitored by silica gel thin layer chromatography, using ethyl acetate: petroleum ether = 1:3 as the chromatographic solvent. The reaction mixture was purified by pentafluorophenyl column with ACN / H2O (v / v=3 / 7) to obtain compound 8-5, i.e. (R)-N-(1-((2R, 3R, 4S, 5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-3-guanidino-4-(2,4,5-trifluorophenyl)butanamide. The amount of compound 8-5 prepared and the volume of the reaction container were enlarged or reduced in accordance with the corresponding proportions. The physicochemical parameters and structural parameters of compound 8-5 are shown in Table 1.
[0022] Table 1 Physicochemical parameters and structural parameters of the fluorinated cytidine guanidine compounds of the present invention Example 2 Preparation of compound 8-5 8 g of the compound (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyric acid and 12 g of cytidine were added to a 50 ml round-bottom flask, vacuumed, and then 10 ml of dry N,N-dimethylformamide (DMF) was added as a solvent, and then 3 g of 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU) and 3 g of N,N-diisopropylethylamine (DIEA) were added as condensation agents, and the mixture was stirred at 35°C for 12 hours. The reaction was monitored by silica gel thin layer chromatography, using ethyl acetate: petroleum ether = 2:5 as the chromatographic liquid. The reaction mixture was purified by pentafluorophenyl column with ACN / H2O (v / v=1 / 4) to obtain compound 8-1, i.e. ((R)-4-((1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate. The amount of compound 8-1 prepared and the volume of the reaction container were scaled up or down in the corresponding proportion.
[0023] 10 g of ((R)-4-((1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate and 4 g of acetic anhydride were added to a 50 ml round-bottom flask, vacuumed, and then 20 ml of acetonitrile (ACN) was added as a solvent, and 3 g of N,N-diisopropylethylamine (DIEA) was added as a condensation agent, and the mixture was stirred at room temperature for 6 hours. The reaction was monitored by silica gel thin layer chromatography, using ethyl acetate: petroleum ether = 2:3 as the chromatographic solvent. The reaction mixture was purified by a pentafluorophenyl column with ACN / H2O (v / v=5 / 2) to obtain compound 8-2, i.e., ((2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-((tert-butyloxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-2 prepared and the volume of the reaction container were scaled up or down in the corresponding proportions.
[0024] 8 g of ((2R,3R,4R,5R)-2-(acetoxymethyl)-5-(4-((R)-3-((tert-butyloxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate was added to a 25 ml round-bottom flask, and vacuum was applied. Then, 4 ml of trifluoroacetic acid (TFA) and 8 ml of dichloromethane (DCM) were added, and the mixture was stirred at room temperature for 5 hours. The progress of the reaction was monitored by silica gel thin layer chromatography. Ethyl acetate: petroleum ether = 2:3 was used as the chromatography liquid. The reaction mixture was purified by a pentafluorophenyl column using ACN / H2O (v / v = 1 / 3) to obtain compound 8-3, i.e. (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-3 prepared and the volume of the reaction container were enlarged or reduced in the corresponding proportion.
[0025] 8 g of (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate and 4 g of 1,1-di-tert-butyloxycarbonyl-2-(trifluoromethylsulfonyl)guanidine were added to a 50 ml round-bottom flask, vacuumed, and then 10 ml of dry N,N-dimethylformamide (DMF) was added as a solvent, and 2 g of N,N-diisopropylethylamine (DIEA) was added as a condensation agent, and the mixture was stirred at room temperature for 24 hours. The reaction was monitored by silica gel thin layer chromatography, using ethyl acetate: petroleum ether = 3:5 as the chromatographic solvent. The reaction mixture was purified by a pentafluorophenyl column with ACN / H2O (v / v=4 / 6) to obtain compound 8-4, i.e., (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-(((R)-3-(2,3-bis(tert-butyloxycarbonyl)guanidino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-4 prepared and the volume of the reaction container were scaled up or down in the corresponding proportions.
[0026] 6 g of (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-(((R)-3-(2,3-bis(tert-butyloxycarbonyl)guanidino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate and 8 ml of hydrochloric acid were added to a 50 ml round-bottom flask, and the mixture was stirred at room temperature for 6 hours. The reaction was monitored by silica gel thin layer chromatography, using ethyl acetate:petroleum ether = 2:4 as the chromatographic solvent. The reaction mixture was purified by a pentafluorophenyl column with ACN / H2O (v / v=5 / 8) to obtain compound 8-5, i.e., (R)-N-(1-((2R, 3R, 4S, 5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-3-guanidino-4-(2,4,5-trifluorophenyl)butanamide. The amount of compound 8-5 prepared and the volume of the reaction container were enlarged or reduced in accordance with the corresponding proportions. The physicochemical parameters and structural parameters of compound 8-5 are shown in Table 1.
[0027] Example 3 Activity test of compound 8-5 against potato virus Y (PVY) on Chenopodium album: The specific steps are as follows: using the dead spot method, first accurately weigh 5 mg of the compound, dissolve it with 0.5 mL of distilled water, then add distilled water containing 1% Tween-80 to make it 50 mL, and prepare a test solution with a mass concentration of 100 mg / L. Ningnanmycin and Lentinan are prepared into a 100 mg / L test solution, and this is used as a control agent, and spraying a Tween-80 aqueous solution without the target compound is used as a blank control. Take fresh virus source leaves in the test, grind them into a homogenate with PBS buffer (pH = 7.2), select 7-8 leaves of Amaranthus quinoa with consistent growth, spray diamond dust (240 mesh) on the leaves, and inoculate the 5th and 6th leaves of each Amaranthus quinoa plant by friction inoculation. After 15 minutes of inoculation, rinse the diamond dust on the leaf surface with clean water. 24 hours after inoculation, spray the agent evenly on the surface of the host leaf for testing. Observe and record the number of dead spots produced 3 days after inoculation, and calculate the dead spot inhibition rate. The calculation method is as follows. The above is the therapeutic activity of compound 8-5 against PVY. The therapeutic activity was also determined. The difference is that in the determination of protective activity, the agent was sprayed first, and the virus was inoculated 24 hours after spraying.
[0028] Necrotic spot inhibition rate (%) = (number of control necrotic spots - number of treated necrotic spots) / number of control necrotic spots × 100 After calculation, the results of the antiviral activity determination (half-leaf spot method) of the fluorinated cytidine guanidine compound 8-5 are shown in Table 2. The results show that the fluorinated cytidine guanidine compound 8-5 synthesized by the present invention has good therapeutic activity and protective activity against potato virus Y on Chenopodium album, which are 55.64% and 72.31% respectively. The protective effect is slightly lower than that of the control agents Ningnanmycin and Lentinan, but the therapeutic effect is higher than that of Ningnanmycin and Lentinan.
[0029] Table 2 Anti-plant virus activity of the fluorine-containing cytidine guanidine compounds of the present invention Example 4 Activity test of compound 8-5 against turnip mosaic virus (TuMV) on Nicotiana benthamiana: The specific steps are as follows: first accurately weigh 4 mg of the compound, dissolve it with 0.5 mL of distilled water, then add distilled water containing 1% Tween-80 to 50 mL to prepare a test solution with a mass concentration of 100 mg / L. Prepare 80 mg / L of test solution with Ningnanmycin and Lentinan as the control agent, and spray the Tween-80 aqueous solution without the target compound as the blank control. Select 5-6 leaves of Bensheng Nicotiana benthamiana with consistent growth, and inject TuMV into the 4th leaf of Bensheng Nicotiana benthamiana by Agrobacterium infiltration method. After 24 hours of virus inoculation, spray the agent evenly on the surface of the host leaf for testing, observe and investigate the disease index within 7 days, and calculate the control effect.
[0030] Virus disease classification and investigation methods are implemented in accordance with the national standard "GB / T 23222-2008". Random disease investigation and records are carried out during the peak period of the disease, and the incidence rate, disease index and relative control effect of each treatment are calculated.
[0031] Disease index = ∑ (disease level × number of diseased plants at that level) / (highest disease level × total number of plants surveyed) × 100 Control effect (%) = [(disease index of blank control area - disease index of treated area) / disease index of blank control area] × 100 After calculation, the results of the determination of the control effect of the fluorinated cytidine guanidine compound 8-5 on pepper virus disease are shown in Table 3. The results show that the fluorinated cytidine guanidine compound 8-5 synthesized by the present invention has a good control effect on TuMV, and the control effect on TuMV is as high as 62.07%, which is slightly lower than the control agents Ningnanmycin and Lentinan.
[0032] Table 3 The control effect of the fluorine-containing cytidine guanidine compounds of the present invention on turnip mosaic virus disease Example 5 Determination of fungicidal activity of compound 8-5: The tested strains are tobacco target spot pathogen (Rhizoctonia solani), rice sheath blight pathogen (Rhizoctonia solani), tobacco root rot pathogen (Fusarium oxysporu), corn Curvularia unata, citrus rot pathogen (Pythium aphanidermatum), pepper anthracnose pathogen (Colletotrichumacutatum), eggplant brown streak pathogen (Phomopsis vexans), wheat fusarium rust pathogen (Gibberellazeae), and corn leaf blight pathogen (Bipolarismaydi). These strains are very representative and can represent most of the species of pathogens occurring in the field in agricultural production.
[0033] The specific steps are as follows: the compound is weighed and dissolved with sterile water using the mycelium growth rate method, and the mother solution with a concentration of 5000 mg / L is prepared by constant volume. Under sterile conditions, 0.33 mL or 0.66 mL of a 5000 mg / L agent is mixed evenly with 33 mL of melted (55±5°C) PDA medium to prepare 33 mL of a drug-containing medium with a concentration of 50 mg / L or 100 mg / L, and then 33 mL of the drug-containing medium is evenly poured into 3 culture dishes with a diameter of 9 cm, 11 mL per dish. After the drug-containing medium in the dish is condensed, the cultured pathogen cakes with a diameter of 0.5 cm are inoculated and placed in a 28°C incubator for 3 days. The colony diameter of each treatment is measured by the cross method, and the average value is taken. The mycelium growth inhibition rate is calculated based on the average diameter of the blank control and the treated colonies after correction.
[0034] Mycelium growth inhibition rate (%) = [(control average diameter - treatment average diameter) / control average diameter] × 100 After calculation, the results of the bactericidal activity determination of the fluorinated cytidine guanidine compound 8-5 are shown in Table 4. The results show that the fluorinated cytidine guanidine compound 8-5 synthesized by the present invention has different degrees of bactericidal activity against different pathogens. At 50 mg / L, compound 8-5 has good activity against tobacco target spot pathogen and rice sheath blight pathogen, which are 53.34% and 50.07% respectively. At 100 mg / L, compound 8-5 has good activity against tobacco target spot pathogen and rice sheath blight pathogen, which are 69.60% and 64.84% respectively, showing a relatively stable inhibitory effect. In addition, the inhibitory effect of compound 8-5 on other pathogens is not obvious.
[0035] Table 4 Antibacterial activity of the fluorinated cytidine guanidine compounds of the present invention (50 mg / L, 100 mg / L) Example 6 Field efficacy test of compound 8-5 in combination with fungicides: The specific steps are as follows: Maodianzi Town, Dandong City, Liaoning Province was used as a test site to conduct a field efficacy test on tobacco target spot. The test agents were 80 mg / L compound 8-5, 30% azoxystrobin suspension, 20% jinggangmycin soluble powder, 30% azoxystrobin·compound 8-5 suspension and 20% jinggangmycin·compound 8-5 soluble powder. The field plot test was set with an application concentration of 150 mL / 667 m2 and two application times, of which the first application time was June, before closing. The second application time was 7 days after the first application.
[0036] The test survey was conducted in accordance with the criteria for field efficacy tests of pesticides (I) and the fungicide control of tobacco target spot disease (refer to the classification standard of tobacco brown spot disease GB / T 23222-2008). Each plot was sampled using the diagonal five-point sampling method, and 10 plants were surveyed at each point. The most seriously ill plants were selected from each cluster and their disease levels were recorded. The disease index was counted before application, and the disease index was surveyed again 1-2 weeks after application. During the survey, the outermost 5 rows around each plot were skipped and not counted to eliminate the influence of duckweed and reduce the marginal effect.
[0037] Rice sheath blight disease classification standards: Level 0: The whole plant is disease-free; Level 1: The lesion area accounts for less than 1% of the leaf area; Level 3: The lesion area accounts for less than 1% to 10% of the leaf area; Level 5: The lesion area accounts for 10% to 30% of the leaf area; Level 7: The lesion area accounts for 31% to 50% of the leaf area; Level 9: The lesion area accounts for more than 51% of the leaf area.
[0038] Where: CK0——disease index of blank control area before application CK1——Disease index of blank control area after application PT0——disease index before application of pesticide in the treatment area PT1——Disease index after pesticide application in the treatment area After calculation, the field control effect results of compound 8-5 combined with fungicides are shown in Table 5. The results show that when compound 8-5 is 80 mg / L, the control effect of compound 8-5 on tobacco target spot in the field is lower than that of the control agents 30% azoxystrobin suspension and 20% jinggangmycin soluble powder, which is 55.02% after the first application and 58.20% after the second application. After being used in combination with the two control agents, the relative control effect is greatly increased. Among them, after being used in combination with 30% azoxystrobin suspension, the control effect after the first application is increased to 76.17%, and the control effect after the second application is increased to 81.51%. After being used in combination with 20% jinggangmycin soluble powder, the control effect after the first application is increased to 75.80%, and the control effect after the second application is increased to 81.51%.
[0039] Table 5 The efficacy of the fluorine-containing cytidine guanidine compounds of the present invention in combination with fungicides against tobacco target spot The above embodiments are only preferred embodiments for fully illustrating the present invention, and the protection scope thereof is not limited thereto. Equivalent substitutions or changes made by technicians in the technical field on the basis of the present invention are all within the protection scope of the present invention, and the protection scope of the present invention shall be subject to the claims.
[0040] Those skilled in the art will readily appreciate other embodiments of the present invention after considering the specification and practicing the schemes disclosed herein. The present invention is intended to cover any variations, uses or adaptations of the present invention that follow the general principles of the present invention and include common knowledge or customary techniques in the art that are not disclosed in this disclosure. The description and examples are to be considered exemplary only, and the true scope and spirit of the present invention are indicated by the claims.
Claims
1. A fluorine-containing cytidine guanidine compound, It is characterized in that Chemical name: (R)-N-(1-((2R, 3R, 4S, 5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-3-guanidino-4-(2,4,5-trifluorophenyl)butanamide, Chemical formula: C 20 H 23 N 6 O 6 F 3 , has the following structure: 。 2. According to the method for synthesizing a fluorine-containing cytidine compound according to claim 1, the specific synthesis route is as follows: 。 3. A method for synthesizing a fluorine-containing cytidine compound according to claim 1, It is characterized in that It is divided into the following steps: A. Preparation of compound 8-1: 4-12 g of the compound (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyric acid and 4-12 g of cytosine nucleoside were added to a 50 ml round-bottom flask, and vacuum was applied. Then, 5-10 ml of dry N,N-dimethylformamide (DMF) was added as a solvent, and 2-6 g of 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate HATU and 2-8 g of N,N-diisopropylethylamine DIEA were added as a condensing agent. The mixture was stirred at 25-35°C for 4-16 hours and filtered through a silica gel thin film. The reaction was monitored by HPLC, using ethyl acetate: petroleum ether = 1-4: 2-5 as the chromatographic liquid, and the reaction mixture was purified by pentafluorophenyl column with ACN / H2O to obtain compound 8-1, i.e. ((R)-4-((1-((2R, 3R, 4S, 5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate, and the amount of compound 8-1 prepared and the volume of the reaction container were enlarged or reduced according to the corresponding proportion; B. Preparation of compound 8-2: 4-12 g of ((R)-4-((1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate and 2-6 g of acetic anhydride are added to a 50 ml round-bottom flask, and the flask is evacuated. Then, 15-30 ml of acetonitrile ACN is added as a solvent, and 1-8 g of N,N-diisopropylethylamine DIEA is added as a condensing agent. The mixture is stirred at room temperature for 3-6 hours and condensed with silica gel. The reaction was monitored by thin layer chromatography, using ethyl acetate: petroleum ether = 1-4: 2-5 as the chromatography liquid, and the reaction mixture was purified by pentafluorophenyl column with ACN / H2O to obtain compound 8-2, i.e. ((2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-((tert-butyloxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate, and the amount of compound 8-2 prepared and the volume of the reaction container were enlarged or reduced according to the corresponding proportion; C. Preparation of compound 8-3: 4-12 g of ((2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-((tert-butyloxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate was added to a 25 ml round-bottom flask, and the mixture was evacuated. Then, 1-8 ml of trifluoroacetic acid (TFA) and 5-15 ml of dichloromethane (DCM) were added, and the mixture was stirred at room temperature for 3-5 hours and monitored by silica gel thin layer chromatography. The reaction was tested, ethyl acetate: petroleum ether = 1-4: 2-5 was used as a chromatographic liquid, and the reaction mixture was purified by a pentafluorophenyl column with ACN / H2O to obtain compound 8-3, i.e. (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-3 prepared and the volume of the reaction container were enlarged or reduced according to the corresponding proportions; D. Preparation of compound 8-4: 4-8 g of (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate and 2-4 g of 1,1-di-tert-butyloxycarbonyl-2-(trifluoromethylsulfonyl)guanidine are added to a 50 ml round-bottom flask, and the flask is evacuated. Then, 5-10 ml of dry N,N-dimethylformamide (DMF) is added as a solvent, and 1-5 g of N,N-diisopropylethylamine (DIEA) is added as a condensing agent, and the mixture is stirred at room temperature. Stir for 16 to 24 hours, monitor the progress of the reaction by silica gel thin layer chromatography, use ethyl acetate: petroleum ether = 1 to 4: 2 to 5 as the chromatographic liquid, and purify the reaction mixture by pentafluorophenyl column with ACN / H2O to obtain compound 8-4, i.e. (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-(((R)-3-(2,3-bis(tert-butyloxycarbonyl)guanidino)-4-(2,4,5-trifluorophenyl)butanamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate. The amount of compound 8-4 prepared and the volume of the reaction container are enlarged or reduced according to the corresponding proportions; E. Preparation of compound 8-5: 2-8 g of (2R, 3R, 4R, 5R)-2-(acetoxymethyl)-5-(4-(((R)-3-(2,3-bis(tert-butyloxycarbonyl)guanidino)-4-(2,4,5-trifluorophenyl)butyramide)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate and 6-12 ml of hydrochloric acid are added to a 50 ml round-bottom flask, and the mixture is stirred at room temperature for 3-6 hours. The reaction is monitored by silica gel thin layer chromatography and ethyl acetate is used to precipitate the mixture. Ester: petroleum ether = 1-4: 2-5 as the chromatography liquid, the reaction mixture is purified by pentafluorophenyl column with ACN / H2O to obtain compound 8-5, i.e. (R)-N-(1-((2R, 3R, 4S, 5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-3-guanidino-4-(2,4,5-trifluorophenyl)butanamide, the amount of compound 8-5 prepared and the volume of the reaction container are enlarged or reduced according to the corresponding proportion.
4. Use of a fluorine-containing cytidine guanidine compound according to claim 1, It is characterized in that Used as an agricultural antiviral agent.
5. Use of a fluorine-containing cytidine guanidine compound according to claim 4, It is characterized in that The viruses are potato virus Y, turnip mosaic virus and tobacco mosaic virus.
6. Use of a fluorine-containing cytidine guanidine compound according to claim 4, It is characterized in that The pathogens are tobacco target spot pathogen, rice sheath blight pathogen, tobacco root rot pathogen, corn curvature leaf spot pathogen, and citrus phytophthora.
7. Use of a fluorine-containing cytidine guanidine compound according to claim 1, It is characterized in that The invention relates to the use of a combination of fluorinated cytidine guanidine compounds and fungicides in preventing and controlling agricultural, forestry and horticultural plant diseases: The fluorine-containing cytidine guanidine compound is combined with any one or two of the fungicides to form a fungicide composition for preventing and controlling agricultural, forestry and horticultural plant diseases. The fungicide is selected from the group consisting of azoxystrobin, jinggangmycin, metalaxyl, kasugamycin, methyl thiophanate, mebendazim, carbendazim, mancozeb, thiram, benomyl, bensulfuron, thiabendazole, sclerotin, procymidone, propamocarb, polyoxin, oxepiconazole, propiconazole, prothioconazole, picoxystrobin, benoxystrobin, thiopyrad, imazalil, quinclorac, thiopyrad, flutolanil, fluoxastrobin, kresoxim-butyl, benoxystrobin, oxazolidinone, pyraclostrobin, pyraclostrobin, oxazolidinone, and oxazolidinone.
8. Use of a fluorine-containing cytidine guanidine compound according to claim 7, It is characterized in that The mass percentage of the fluorinated cytidine guanidine compound in the bactericidal composition is 1%-90%, and the mass percentage of the fluorinated cytidine guanidine compound to the aforementioned bactericide is 1%:99% to 99%:1%; the dosage form processed by the bactericidal composition is selected from: seed treatment emulsion, aqueous emulsion, microemulsion, suspoemulsion, soluble concentrate, microgranule oil suspension, oil dispersible powder.
9. Use of a fluorine-containing cytidine guanidine compound according to claim 7, It is characterized in that The plant diseases controlled by the fungicidal composition are selected from: rice sheath blight, corn leaf spot, corn leaf spot, rice blast, tobacco target spot, tobacco brown spot, wheat head blight, pepper anthracnose, tobacco root rot, corn curvature leaf spot, fruit pythium, eggplant brown streak, tomato root rot, strawberry powdery mildew, potato late blight, tobacco black shank, wheat rust, grape downy mildew, cucumber downy mildew, cucumber anthracnose, tomato gray mold; The plants controlled by the fungicidal composition are selected from: rice, wheat, barley, oats, corn, sorghum, cucumber, pepper, potato, sweet potato, cassava, rapeseed, cabbage, beet, tomato, tobacco, soybean, snow pea, broad bean, pea, mung bean, adzuki bean, cotton, sericulture, peanut, rapeseed, sesame, sunflower, and sugarcane.
